[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HRP20100260T1 - Postupak za proizvodnju stroncij ranelata i njegovih hidrata - Google Patents

Postupak za proizvodnju stroncij ranelata i njegovih hidrata Download PDF

Info

Publication number
HRP20100260T1
HRP20100260T1 HR20100260T HRP20100260T HRP20100260T1 HR P20100260 T1 HRP20100260 T1 HR P20100260T1 HR 20100260 T HR20100260 T HR 20100260T HR P20100260 T HRP20100260 T HR P20100260T HR P20100260 T1 HRP20100260 T1 HR P20100260T1
Authority
HR
Croatia
Prior art keywords
formula
process according
synthesis process
iii
reaction
Prior art date
Application number
HR20100260T
Other languages
English (en)
Croatian (hr)
Inventor
Vaysse-Ludot Lucile
Lecouve Jean-Pierre
Langlois Pascal
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39431194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100260(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20100260T1 publication Critical patent/HRP20100260T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
HR20100260T 2007-09-26 2010-05-11 Postupak za proizvodnju stroncij ranelata i njegovih hidrata HRP20100260T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706731A FR2921367B1 (fr) 2007-09-26 2007-09-26 Nouveau procede de synthese du ranelate de strontium et de ses hydrates

Publications (1)

Publication Number Publication Date
HRP20100260T1 true HRP20100260T1 (hr) 2010-06-30

Family

ID=39431194

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100260T HRP20100260T1 (hr) 2007-09-26 2010-05-11 Postupak za proizvodnju stroncij ranelata i njegovih hidrata

Country Status (47)

Country Link
US (2) US8063100B2 (sl)
EP (1) EP2042497B1 (sl)
JP (1) JP5016575B2 (sl)
KR (1) KR101099995B1 (sl)
CN (1) CN101397292A (sl)
AP (1) AP2400A (sl)
AR (1) AR068535A1 (sl)
AT (1) ATE460408T1 (sl)
AU (1) AU2008221618B2 (sl)
BR (1) BRPI0803636A2 (sl)
CA (1) CA2640041C (sl)
CL (1) CL2008002833A1 (sl)
CO (1) CO6110143A1 (sl)
CR (1) CR10292A (sl)
CY (1) CY1110036T1 (sl)
DE (1) DE602008000790D1 (sl)
DK (1) DK2042497T3 (sl)
EA (1) EA014247B1 (sl)
EC (1) ECSP088771A (sl)
ES (1) ES2342233T3 (sl)
FR (1) FR2921367B1 (sl)
GE (1) GEP20115191B (sl)
GT (1) GT200800190A (sl)
HN (1) HN2008001490A (sl)
HR (1) HRP20100260T1 (sl)
IL (1) IL194089A (sl)
JO (1) JO2964B1 (sl)
MA (1) MA30319B1 (sl)
ME (1) ME01849B (sl)
MX (1) MX2008012119A (sl)
MY (1) MY144180A (sl)
NI (1) NI200800257A (sl)
NZ (1) NZ571511A (sl)
PA (1) PA8797001A1 (sl)
PE (1) PE20090703A1 (sl)
PL (1) PL2042497T3 (sl)
PT (1) PT2042497E (sl)
RS (1) RS51356B (sl)
SA (1) SA08290594B1 (sl)
SG (1) SG151207A1 (sl)
SI (1) SI2042497T1 (sl)
SV (1) SV2008003033A (sl)
TW (1) TWI358408B (sl)
UA (1) UA97638C2 (sl)
UY (1) UY31341A1 (sl)
WO (1) WO2009074741A2 (sl)
ZA (1) ZA200808176B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates
EP2346846A1 (en) * 2008-09-29 2011-07-27 Ratiopharm GmbH Anhydrate and hydrate forms of strontium ranelate
HU228820B1 (en) 2010-01-14 2013-05-28 Richter Gedeon Nyrt Process for the preparation of distrontium ranelate
IT1398542B1 (it) * 2010-03-05 2013-03-01 Chemelectiva S R L Processo per la preparazione di un polimorfo
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
WO2011124992A1 (en) * 2010-03-24 2011-10-13 Actavis Group Ptc Ehf Substantially pure strontium ranelate
US20110275834A1 (en) * 2010-05-06 2011-11-10 Divi's Laboratories, Limited Polymorph of strontium ranelate and a process for its preparation
WO2012046251A2 (en) * 2010-10-08 2012-04-12 Glenmark Generics Limited Novel form of ranelic acid
CZ2011320A3 (cs) * 2011-05-30 2012-12-12 Zentiva, K.S. Stabilní krystalická forma X stroncium ranelátu
CN102391247B (zh) * 2011-09-20 2016-12-28 浙江华海药业股份有限公司 一种雷尼酸锶水合物晶形k及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
GB2235691A (en) * 1989-09-04 1991-03-13 Du Pont Canada Concentrates of modifying agents in polymers
JP3880262B2 (ja) * 1998-11-02 2007-02-14 株式会社カネカ 水不溶化再生コラーゲン繊維の製造方法
FR2844797B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
US7138529B2 (en) * 2003-04-16 2006-11-21 Hoffmann-La Roche Inc. Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
AU2006281157B2 (en) * 2005-08-19 2013-03-28 Glenmark Pharmaceuticals Limited Process for the preparation of strontium ranelate
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
CN100554263C (zh) * 2006-07-19 2009-10-28 天津药物研究院 雷奈酸锶七水合物的制备方法
FR2921367B1 (fr) * 2007-09-26 2009-10-30 Servier Lab Nouveau procede de synthese du ranelate de strontium et de ses hydrates

Also Published As

Publication number Publication date
AU2008221618A1 (en) 2009-04-09
PE20090703A1 (es) 2009-06-27
KR20090032009A (ko) 2009-03-31
HN2008001490A (es) 2010-10-08
BRPI0803636A2 (pt) 2009-06-02
MX2008012119A (es) 2009-03-25
TW200920743A (en) 2009-05-16
EP2042497B1 (fr) 2010-03-10
JO2964B1 (en) 2016-03-15
AR068535A1 (es) 2009-11-18
WO2009074741A2 (fr) 2009-06-18
US8063100B2 (en) 2011-11-22
AP2400A (en) 2012-04-30
SI2042497T1 (sl) 2010-06-30
RS51356B (en) 2011-02-28
UY31341A1 (es) 2008-10-31
EA200801884A1 (ru) 2009-04-28
CN101397292A (zh) 2009-04-01
GT200800190A (es) 2010-05-21
CL2008002833A1 (es) 2009-08-07
TWI358408B (en) 2012-02-21
PL2042497T3 (pl) 2010-06-30
NI200800257A (es) 2011-01-12
US20120029210A1 (en) 2012-02-02
WO2009074741A3 (fr) 2009-11-26
PT2042497E (pt) 2010-04-28
CR10292A (es) 2008-11-26
MA30319B1 (fr) 2009-04-01
UA97638C2 (ru) 2012-03-12
FR2921367B1 (fr) 2009-10-30
ZA200808176B (en) 2010-02-24
ES2342233T3 (es) 2010-07-02
CO6110143A1 (es) 2009-12-31
GEP20115191B (en) 2011-03-25
PA8797001A1 (es) 2009-09-17
AU2008221618B2 (en) 2012-02-09
MY144180A (en) 2011-08-15
JP5016575B2 (ja) 2012-09-05
SV2008003033A (es) 2010-01-21
SG151207A1 (en) 2009-04-30
EA014247B1 (ru) 2010-10-29
ME01849B (me) 2011-02-28
NZ571511A (en) 2010-01-29
DE602008000790D1 (de) 2010-04-22
ECSP088771A (es) 2009-02-27
SA08290594B1 (ar) 2011-02-23
ATE460408T1 (de) 2010-03-15
EP2042497A1 (fr) 2009-04-01
US20090082578A1 (en) 2009-03-26
IL194089A (en) 2016-04-21
IL194089A0 (en) 2009-11-18
KR101099995B1 (ko) 2011-12-28
CA2640041C (fr) 2011-03-08
CY1110036T1 (el) 2015-01-14
AP2008004617A0 (en) 2008-10-31
JP2009132676A (ja) 2009-06-18
DK2042497T3 (da) 2010-06-07
FR2921367A1 (fr) 2009-03-27
CA2640041A1 (fr) 2009-03-26

Similar Documents

Publication Publication Date Title
HRP20100260T1 (hr) Postupak za proizvodnju stroncij ranelata i njegovih hidrata
SU982537A3 (ru) Способ получени производных фенилэтаноламина или их солей
HRP20150945T1 (hr) Postupci za proizvodnju derivata benzil-benzena supstituiranog glukopiranozilom
JP2013506706A5 (sl)
RU2012117978A (ru) Способ синтеза эрготионеина и его аналогов
HRP20200488T1 (hr) Proizvodnja 4,5,6,7-tetrahidroizozaksolo[5,4-c]piridin-3-ola
HRP20140431T1 (hr) Postupak za jodiranje aromatskih tvari
WO2010064109A3 (en) An improved process for the preparation of montelukast sodium and its intermediates
NZ577081A (en) Synthesis of compounds useful as modulators of amyloid-beta production
SE452610B (sv) Sett att spalta racemiska cis-1,2-cyklopropandikarboxylsyraderivat
CN101585769B (zh) 没食子酸酯的微波合成方法
JP7142639B2 (ja) 2-シアノイミダゾール化合物の調製方法
FI3461807T3 (fi) Uudenlaisten detergenttien suunnittelu ja kehitys pcr-järjestelmissä käyttöä varten
CN105906537A (zh) (z)式磺酰基烯酸酯化合物的一锅合成方法
DK2571887T3 (en) A process for the preparation of dithiine-tetracarboxy-diimides
WO2018065924A1 (en) Intermediates of mitogen-activated protein kinase kinase (map2k or mek) inhibitors and process for their preparation
WO2008140338A4 (en) New ionic pairs with (4-chloro-2-methylphenoxy)acetate and their syntheses
HRP20170394T1 (hr) Postupak za sintezu 3,4-dimetoksibiciklo[4.2.0]okta-1,3,5-trien-7-karbonitrila i uporaba za sintezu ivabadina i njegovih adicijskih soli s farmacetuski prihvatljivom kiselinom
WO2010021000A3 (en) A process for the preparation of strontium ranelate
BR112020010618B1 (pt) Método para preparar acetato de salicilamina
HRP20211219T1 (hr) Postupak priprave inhibitora fosfodiesteraze 4
CN106831487B (zh) 有机电子产品中间体芴类衍生物的制备方法
MX2013014312A (es) Procedimiento para la preparacion de pirazolilcarboxanilidas.
HRP20070379A2 (en) Amfifile oxalamide gelators for organic solvents, water and commercial carbohydrate fuels gelation
HRP20150924T1 (hr) Postupak sinteze derivata 7,8-dimetoksi-1,3-dihidro-2h-3-benzazepin-2-ona i njihova uporaba za pripravu ivabradina